EmulsiFlex-C3 Homogenizer

The National Institutes of Health, under the Department of Health and Human Services, is procuring an EmulsiFlex-C3 Homogenizer with an integrated heat exchanger and heat exchange coil through a sole-source acquisition to support high-pressure cell disruption for protein extraction and purification in the Laboratory of Molecular Biology located in Bethesda, Maryland. This procurement, identified by solicitation number 75N98026Q00319, is being conducted under FAR 6.302-1 due to the unique capability of Avestin Inc. to supply this specific equipment, which is essential for maintaining research throughput and preventing delays in critical biological sample preparation. The acquisition is structured as a Firm-Fixed-Price Purchase Order, with a notice of intent posted on May 5, 2026, and responses required by May 15, 2026, via email to David Shen at david.shen@nih.gov. No competitive evaluation factors, pricing details, or formal inspection criteria are included, as this is not a competitive solicitation but rather a pre-award notice to confirm vendor suitability. The place of performance and delivery is Bethesda, Maryland, where the equipment will be inspected and accepted by the government. No packaging, marking, invoicing, or payment instructions are specified in the available documentation, and while small business participation is acknowledged as permissible, the sole-source justification predetermines Avestin Inc. as the awarded contractor. The contract administration remains unspecified in terms of COR, COTR, or PCO designation, and no representations or certifications from the vendor are provided or required at this stage.